255 related articles for article (PubMed ID: 36316536)
1. B cell phenotype, activity, and function in idiopathic nephrotic syndrome.
Liu J; Guan F
Pediatr Res; 2023 Jun; 93(7):1828-1836. PubMed ID: 36316536
[TBL] [Abstract][Full Text] [Related]
2. The immunopathogenesis of idiopathic nephrotic syndrome: a narrative review of the literature.
Kitsou K; Askiti V; Mitsioni A; Spoulou V
Eur J Pediatr; 2022 Apr; 181(4):1395-1404. PubMed ID: 35098401
[TBL] [Abstract][Full Text] [Related]
3. Rituximab in idiopathic nephrotic syndrome: does it make sense?
Cara-Fuentes G; Kairalla JA; Ishimoto T; Rivard C; Johnson RJ; Garin EH
Pediatr Nephrol; 2014 Aug; 29(8):1313-9. PubMed ID: 23793923
[TBL] [Abstract][Full Text] [Related]
4. B-Cell Dysregulation in Idiopathic Nephrotic Syndrome: What We Know and What We Need to Discover.
Colucci M; Oniszczuk J; Vivarelli M; Audard V
Front Immunol; 2022; 13():823204. PubMed ID: 35140723
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 3 expression and function in childhood idiopathic nephrotic syndrome.
Jamin A; Dehoux L; Dossier C; Fila M; Heming N; Monteiro RC; Deschênes G
Clin Exp Immunol; 2015 Dec; 182(3):332-45. PubMed ID: 26123900
[TBL] [Abstract][Full Text] [Related]
6. The extrafollicular B cell response is a hallmark of childhood idiopathic nephrotic syndrome.
Al-Aubodah TA; Aoudjit L; Pascale G; Perinpanayagam MA; Langlais D; Bitzan M; Samuel SM; Piccirillo CA; Takano T
Nat Commun; 2023 Nov; 14(1):7682. PubMed ID: 37996443
[TBL] [Abstract][Full Text] [Related]
7. Prolonged Impairment of Immunological Memory After Anti-CD20 Treatment in Pediatric Idiopathic Nephrotic Syndrome.
Colucci M; Carsetti R; Serafinelli J; Rocca S; Massella L; Gargiulo A; Lo Russo A; Capponi C; Cotugno N; Porzio O; Onetti Muda A; Palma P; Emma F; Vivarelli M
Front Immunol; 2019; 10():1653. PubMed ID: 31379849
[TBL] [Abstract][Full Text] [Related]
8. Natural antibody and complement activation characterize patients with idiopathic nephrotic syndrome.
Trachtman H; Laskowski J; Lee C; Renner B; Feemster A; Parikh S; Panzer SE; Zhong W; Cravedi P; Cantarelli C; Kulik L; You Z; Satchell S; Rovin B; Liu F; Kalled SL; Holers VM; Jalal D; Thurman JM
Am J Physiol Renal Physiol; 2021 Oct; 321(4):F505-F516. PubMed ID: 34459222
[TBL] [Abstract][Full Text] [Related]
9. CyTOF-Enabled Analysis Identifies Class-Switched B Cells as the Main Lymphocyte Subset Associated With Disease Relapse in Children With Idiopathic Nephrotic Syndrome.
Fribourg M; Cioni M; Ghiggeri G; Cantarelli C; Leventhal JS; Budge K; Bin S; Riella LV; Colucci M; Vivarelli M; Angeletti A; Perin L; Cravedi P
Front Immunol; 2021; 12():726428. PubMed ID: 34621271
[TBL] [Abstract][Full Text] [Related]
10. Immunopathogenesis of idiopathic nephrotic syndrome with relapse.
Sahali D; Sendeyo K; Mangier M; Audard V; Zhang SY; Lang P; Ollero M; Pawlak A
Semin Immunopathol; 2014 Jul; 36(4):421-9. PubMed ID: 24402710
[TBL] [Abstract][Full Text] [Related]
11. Circulating plasmablasts and high level of BAFF are hallmarks of minimal change nephrotic syndrome in adults.
Oniszczuk J; Beldi-Ferchiou A; Audureau E; Azzaoui I; Molinier-Frenkel V; Frontera V; Karras A; Moktefi A; Pillebout E; Zaidan M; El Karoui K; Delfau-Larue MH; Hénique C; Ollero M; Sahali D; Mahévas M; Audard V
Nephrol Dial Transplant; 2021 Mar; 36(4):609-617. PubMed ID: 33241414
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of IgM and C1q deposition in the mesangium in pediatric idiopathic nephrotic syndrome.
Kanemoto K; Ito H; Anzai M; Matsumura C; Kurayama H
J Nephrol; 2013; 26(2):306-14. PubMed ID: 22641570
[TBL] [Abstract][Full Text] [Related]
13. The role of the immune system in idiopathic nephrotic syndrome.
Hackl A; Zed SEDA; Diefenhardt P; Binz-Lotter J; Ehren R; Weber LT
Mol Cell Pediatr; 2021 Nov; 8(1):18. PubMed ID: 34792685
[TBL] [Abstract][Full Text] [Related]
14. [Minimal change nephrotic syndrome : new insights into disease pathogenesis].
Audard V; Lang P; Sahali D
Med Sci (Paris); 2008 Oct; 24(10):853-8. PubMed ID: 18950582
[TBL] [Abstract][Full Text] [Related]
15. Genetic Variants of Interleukin-4 in Romanian Patients with Idiopathic Nephrotic Syndrome.
Tieranu I; Tieranu CG; Dutescu MI; Berghea CE; Balgradean M; Popa OM
Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208588
[No Abstract] [Full Text] [Related]
16. The role of the immune system in idiopathic nephrotic syndrome: a review of clinical and experimental studies.
Pereira Wde F; Brito-Melo GE; Guimarães FT; Carvalho TG; Mateo EC; Simões e Silva AC
Inflamm Res; 2014 Jan; 63(1):1-12. PubMed ID: 24121975
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children.
Ravani P; Bonanni A; Rossi R; Caridi G; Ghiggeri GM
Clin J Am Soc Nephrol; 2016 Apr; 11(4):710-20. PubMed ID: 26585985
[TBL] [Abstract][Full Text] [Related]
18. Vascular hyperpermeability in nephrotic edema.
Rostoker G; Behar A; Lagrue G
Nephron; 2000 Jul; 85(3):194-200. PubMed ID: 10867533
[TBL] [Abstract][Full Text] [Related]
19. Serum immunoglobulins in the nephrotic syndrome. A possible cause of minimal-change nephrotic syndrome.
Giangiacomo J; Cleary TG; Cole BR; Hoffsten P; Robson AM
N Engl J Med; 1975 Jul; 293(1):8-12. PubMed ID: 1079322
[TBL] [Abstract][Full Text] [Related]
20. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
Horinouchi T; Sako M; Nakanishi K; Ishikura K; Ito S; Nakamura H; Oba MS; Nozu K; Iijima K
BMC Nephrol; 2018 Nov; 19(1):302. PubMed ID: 30382824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
